CTRI/2008/091/000194CompletedPhase 2
Phase II Trial of Curcumin in Advanced Head and Neck Cancer Treatment
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- DBT
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients with histo-pathological confirmed squamous cell carcinoma of head and neck (oral cavity/ pharynx/ larynx)
- •2. Patients who have advanced incurable cancer of head and neck region at the initial diagnosis or those who have failed all standard cancer specific treatment including chemotherapy, radiotherapy
- •3. Patient has signed and dated the informed consent document
- •4. Patient is willing and able to fully participate for the duration of the study
- •5. Patient with anticipated life of more than two months on clinical assessment by team members
Exclusion Criteria
- •1. Patient is less than 18 years of age
- •2. Patient is participating in any other study
- •3. Patient with non-squamous cell cancers
- •4. Patient who does not comply with assigned treatment protocol
- •5. Patient with potential behavior and cognitive impairment
Investigators
Similar Trials
Terminated
Not Applicable
Efficacy and Safety of Curcumin Formulation in Alzheimer's DiseaseAlzheimer DiseaseNCT01001637Jaslok Hospital and Research Centre26
Not yet recruiting
Phase 2
The effect of curcumin (a substance extracted from turmeric) on the immune system and clinical signs in patients with rheumatoid arthritisIRCT20220309054225N1Yazd University of Medical Sciences30
Completed
Phase 1
A phase I/IIa study combining curcumin (Curcumin C3 Complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancerCancerISRCTN58705307niversity of Leicester (UK)28
Completed
Not Applicable
Effect of curcumin (tumeric) on patients with Metabolic syndromeIRCT201512181165N12Baghiyatallah University of Medical Sciences100
Completed
Phase 2
Effect of curcuminoids supplementation in treatment of methadone maintenance treatment patientsIRCT20170420033551N8Kashan University of Medical Sciences60